Irish Study Finds Cystic Fibrosis Drug Safe for Newborns


An RCSI and Children's Health Ireland study has shown that Ivacaftor is safe for treating newborns with cystic fibrosis from four weeks old.
Silicon Republic 2:15 pm on April 11, 2024


Featured Image Related to Story


https://www.siliconrepublic.com/innovation/cystic-fibrosis-treatment-rcsi-study-ivacaftor

< Previous Story     -     Next Story >

Copy and Copyright Pubcon Inc.
1996-2024 all rights reserved. Privacy Policy.
All trademarks and copyrights held by respective owners.